| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |